Replacement heart valves once again take center stage at the annual EuroPCR conference in Paris this week, as Edwards Lifesciences pauses its Fortis trial and positive new data comes in on the next generation of aortic implants.
News Well, Cardiovascular, EuroPCR 2015, Peripheral Artery Disease, Replacement Heart Valves, Stents
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1c9MTWU
Cap comentari:
Publica un comentari a l'entrada